Diagnosis of circulatory antibodies to Chlamydia trachomatis among asymptomatic undifferentiated spondyloarthropathy patients in India

Praveen Kumar, Geetika Khanna, Sumit Batra, Vinod Kumar Sharma, Sangita Rastogi
DOI: 10.15305/ijrci/v1iS1/50



C. trachomatis infection has been reported in patients with undifferentiated spondyloarthropathy (uSpA). However, it is underdiagnosed globally, including India.


The aim of the study was to determine circulatory anti-Chlamydia trachomatis antibodies in uSpA patients.

Materials and methods

Twenty two uSpA patients were included in the study following the European Spondylarthropathy Study Group (ESSG) criteria and 12 age- and sex- matched osteoarthritis patients were also included for comparison. From each patient, 5 ml of non-heparinized intravenous blood was collected for analysis. Anti-C. trachomatis IgG and IgA antibodies were detected in serum using commercially available ELISA kits and  the data was statistically evaluated.


During the study, 18.1% (4/ 22) uSpA patients were found positive for anti-C. trachomatis IgA antibodies, while 4.5% (1/ 22) patients were positive for anti-C.trachomatis IgG antibodies in serum. None of the control patients was positive for these antibodies.


C. trachomatis may be an unrecognized cause for uSpA even among Indian patients. Further studies involving larger study population are significant to substantiate the findings.


Kumar P, Khanna G, Batra S, Sharma VK, Rastogi S. IJRCI. 2013;1(S1):SO1.


Chlamydia trachomatis -- undifferentiated spondyloarthropathy -- antibodies


1. Eric G, Robert DI. Chlamydia-induced ReA: Immune imbalances and persistent pathogens. Nat Rev Rheumatol. 2012; 8: 55–9.

2. Aggarwal A, Misra R, Chandrasekhar S, Prasad KN, Dayal R, Ayyagari A. Is undifferentiated seronegative spondyloarthropathy a forme fruste of reactive arthritis? Rheumatology 1997; 36: 1001-4.

3. Carter JD, Gérard HC, Espinoza LR, Ricca LR, Valeriano J, Snelgrove J, Oszust C, Vasey FB, Hudson AP. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum. 2009; 60(5): 1311-6.

4. Kathryn S. Chlamydia: A much underestimated STI. The Lancet Infectious Diseases 2012; 12(7): 517-18.

5. Chandrashekara S, Aggarwal A, Prasad K N, Misra R. Sporadic reactive arthritis in north India: Lack of IgA Response. J Indian Rheumatol Assoc. 2004; 12: 134-38.

6. Rastogi S, Das B, Mittal A. Serum IgM to Chlamydia trachomatis in pregnancy: Its usefulness for screening. Br J Biomed Sci. 2002; 59 (1): 30-4.

7. Rastogi S, Das B, Salhan S, Mittal A. Effect of treatment for Chlamydia trachomatis during pregnancy. Int J Gynecol Obstet. 2003; 80: 129-37.

8. Kumar P, Bhakuni DS, Mullick G, Kartik S, Rastogi S. Diagnosis of Chlamydia trachomatis in joint fluid of chronic reactive arthritis and undifferentiated spondyloarthropathy patients. Indian Journal of Rheumatology 2012; S (7): S1-S6.

9. Kumar P, Khanna G, Batra S, Sharma VK, Rastogi S. A pilot study for detection of intra-articular chromosomal and extra-chromosomal genes of Chlamydia trachomatis among genitourinary reactive arthritis patients in India. International Research Journal of Medical Sciences 2013; 1(4): 16-20.

10. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al & European Spondylarthropathy Study Group. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum. 1991; 34: 1218-27.

11. Boyer GS, Templin DW, Bowler A, Lawrence RC, Heyse SP, Everett DF, Cornoni-Huntley JC. Spondyloarthropathy in the community: Clinical syndromes and disease manifestations in Alaskan eskimo populations. J Rheumatol. 1999; 26(7): 1537–44.

12. Bas S, Vischer TL. Chlamydia trachomatis antibody detection and diagnosis of reactive arthritis. Br J Rheum. 1998; 37: 1054-59.